Genus/GNS

-2.86%
-
1D1W1MYTD1YMAX

About Genus

Genus plc is a United Kingdom-based animal protein genetics company. The Company supplies breeding animals with desirable characteristics for farmers, enabling them to produce quality meat and milk. Its segments include Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in the porcine sales business. The Genus ABS segment is engaged in the bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. It also provides technical services and advice to farmers, to maximize the performance of its breeding animals in their farms. The Company has supply chain and distribution networks in over 80 countries.

Ticker

GNS

Sector

Healthcare

Trading on

LSE

Industry

Biotechnology & Drugs

CEO

Jorgen Kokke

Employees

3,476

Headquarters

Basingstoke, United Kingdom

Genus Metrics

BasicAdvanced
£1.16B
Market cap
34.63
P/E ratio
£0.51
EPS
0.26
Beta
£0.32
Dividend rate
1.83%
Dividend yield
£1.16B
0.25774
£27.87
£14.78
131.16K
£0.32
2.152
1.403
47.599
50.818
62.87%
65.291
5.44%
2.9%
5.79%
3.3%
34.632
1.717
2.01
2.922
0.97%
1.83%
1.83%
1.62%
-3.61%
7.75%
-2.21%
3.22%

What the Analysts think about Genus

Analyst Ratings

Majority rating from 7 analysts.
Buy

Price Targets

Average projection from 7 analysts.
67.35% upside
High £35.00
Low £21.50
£17.00
Current price
£28.45
Average price target

Genus Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
4.04% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
£333.6M
-1.74%
Net income
£13.5M
-32.16%
Profit margin
4.04%
-31.06%

Genus Earnings Performance

No data availble
Quarterly data is not available. You can look at the annual data instead.

Earnings per share (EPS)

Company profitability
-
QuarterlyAnnual
Actual
Expected
Surprise
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Genus stock?

Genus (GNS) has a market cap of £1.16B as of April 24, 2024.

What is the P/E ratio for Genus stock?

The price to earnings (P/E) ratio for Genus (GNS) stock is 34.63 as of April 24, 2024.

Does Genus stock pay dividends?

Yes, the Genus (GNS) stock pays dividends to shareholders. As of April 24, 2024, the dividend rate is £0.32 and the yield is 1.83%. Genus has a payout ratio of 62.87% on a trailing twelve-month basis.

When is the next Genus dividend payment date?

The next Genus (GNS) dividend payment date is unconfirmed.

What is the beta indicator for Genus?

Genus (GNS) has a beta rating of 0.26. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Genus stock price target?

The target price for Genus (GNS) stock is £28.45, which is 67.35% above the current price of £17. This is an average based on projections from 7 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Genus stock

Buy or sell Genus stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing